BDNF and major depressive disorder: To treat depression, EA can inhibit hyperexcitability of the HPA axis, decrease levels of inflammatory cytokines, enhance BDNF expression, restore hippocampal synaptic plasticity, regulate neuropeptides and neurotransmitters bidirectionally, and stimulate signal transduction pathways and genomic expression (78).